Dyslipidemia and lipid management in HIV-infected patients (Q35160574)

6 August 2017

4 references

1 July 2020

18 December 2020

28 January 2021

25 October 2022

Dyslipidemia and lipid management in HIV-infected patients (English)

1 reference

human immunodeficiency virus infectious disease

6 August 2017

1 reference

1 July 2020

1 reference

8 August 2019

2 references

2 October 2019

18 December 2020

1 reference

19 November 2019

2 references

28 January 2021

Janet Lo

1

1 reference

PubMed ID

21297466

6 August 2017

language of work or name

1 reference

1 April 2011

13 references

Current Opinion in Endocrinology, Diabetes and Obesity

6 August 2017

23 March 2019

24 March 2019

22 June 2019

8 August 2019

2 October 2019

19 October 2019

19 November 2019

26 April 2020

1 July 2020

18 December 2020

28 January 2021

25 October 2022

13 references

6 August 2017

23 March 2019

24 March 2019

22 June 2019

8 August 2019

2 October 2019

19 October 2019

19 November 2019

26 April 2020

1 July 2020

18 December 2020

28 January 2021

25 October 2022

18

1 reference

6 August 2017

144-147

1 reference

6 August 2017

2

1 reference

Creative Commons Attribution-NonCommercial

6 August 2017

12 references

23 March 2019

24 March 2019

22 June 2019

8 August 2019

2 October 2019

19 October 2019

19 November 2019

26 April 2020

1 July 2020

18 December 2020

28 January 2021

25 October 2022

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Rosiglitazone increases small dense low-density lipoprotein concentration and decreases high-density lipoprotein particle size in HIV-infected patients

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

CD4+ count-guided interruption of antiretroviral treatment

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Drug-drug interactions between raltegravir and pravastatin in healthy volunteers

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Increased carotid intima media thickness and cardiac biomarkers in HIV infected children

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Survival of persons with and without HIV infection in Denmark, 1995-2005.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Combination antiretroviral therapy and the risk of myocardial infarction

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Impact of HIV infection and HAART on serum lipids in men.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3154840

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

16 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21297466

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21297466

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21297466

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/MED.0B013E328344556E

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

PubMed ID

21297466